STOCK TITAN

Merit Medical Systems Inc (MMSI) COO sells 21,449 shares at $85

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Merit Medical Systems' chief operating officer Neil W. Peterson reported selling 21,449 shares of common stock on 2026-08-04 at $85.00 per share, leaving 25,551 shares held directly. He also reports non-qualified stock options on 25,000 shares at a $68.33 exercise price and 13,576 shares at $70.58, vesting in 25% annual installments beginning 08/19/2022 and 02/28/2024, respectively.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Peterson Neil W.
Role CHIEF OPERATING OFFICER
Sold 21,449 shs ($1.82M)
Type Security Shares Price Value
Sale Common Stock, No Par Value 21,449 $85.00 $1.82M
holding Non-qualified stock options (right to buy) F1 -- -- --
holding Non-qualified stock options (right to buy) F2 -- -- --
Holdings After Transaction: Common Stock, No Par Value — 25,551 shares (Direct); Non-qualified stock options (right to buy) — 38,576 shares (Direct)
Footnotes (2)
  1. F1. Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
  2. F2. Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Shares sold 21,449 shares Common stock sale by COO Neil W. Peterson on 2026-08-04
Sale price $85.00 per share Price for common stock sold on 2026-08-04
Shares held after sale 25,551 shares Direct common stock ownership following the reported sale
Option exercise price $68.33 Non-qualified stock options on 25,000 underlying shares expiring 2028-08-19
Underlying shares at $68.33 25,000 shares Common shares underlying options with a $68.33 exercise price
Option exercise price $70.58 Non-qualified stock options on 13,576 underlying shares expiring 2030-02-28
Underlying shares at $70.58 13,576 shares Common shares underlying options with a $70.58 exercise price
Non-qualified stock options (right to buy) financial
"Security titled "Non-qualified stock options (right to buy)""
underlying security financial
"Described with an underlying security title of "Common Stock""
exercise price financial
"Options reported with an exercise price of $68.33 and $70.58"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did MMSI executive Neil W. Peterson report?

Neil W. Peterson, Merit Medical Systems' chief operating officer, reported selling 21,449 shares of common stock at $85.00 per share on 2026-08-04. After this transaction, he directly holds 25,551 shares of Merit Medical Systems (MMSI) common stock.

How many MMSI shares does Neil W. Peterson hold after his reported sale?

Following the reported sale, Neil W. Peterson directly holds 25,551 shares of Merit Medical Systems (MMSI) common stock. This figure reflects his remaining direct ownership after selling 21,449 shares at $85.00 per share on 2026-08-04.

What MMSI stock option holdings does Neil W. Peterson disclose?

Neil W. Peterson reports two non-qualified stock option positions over MMSI common stock: options on 25,000 shares with a $68.33 exercise price expiring 2028-08-19, and options on 13,576 shares with a $70.58 exercise price expiring 2030-02-28.

At what exercise prices can Neil W. Peterson buy MMSI shares through options?

Neil W. Peterson holds non-qualified stock options to acquire MMSI common stock at exercise prices of $68.33 and $70.58 per share. These cover 25,000 and 13,576 underlying shares, respectively, with both grants vesting in 25% annual installments from their stated commencement dates.

How do Neil W. Peterson’s MMSI options vest over time?

One MMSI option grant for 25,000 shares becomes exercisable in 25% annual installments beginning 08/19/2022. A second grant for 13,576 shares vests in 25% annual installments beginning 02/28/2024, providing staged future exercisability of his non-qualified stock options.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Peterson Neil W.

(Last)(First)(Middle)
1600 W MERIT PARKWAY

(Street)
SOUTH JORDAN UTAH 84095

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF OPERATING OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, No Par Value08/04/2026S21,449D$8525,551D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-qualified stock options (right to buy)$68.3308/19/2022(1)08/19/2028Common Stock25,00025,000D
Non-qualified stock options (right to buy)$70.5802/28/2024(2)02/28/2030Common Stock13,57613,576D
Explanation of Responses:
1. Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.
2. Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
/s/ Brian G. Lloyd, Attorney-in-Fact08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)